87 related articles for article (PubMed ID: 5043222)
1. Intermittent dose schedule of mitomycin C (NSC-26980) in solid tumors.
Kenis Y; Stryckmans P
Cancer Chemother Rep; 1972 Apr; 56(2):151. PubMed ID: 5043222
[No Abstract] [Full Text] [Related]
2. Mitomycin (Mutamycin).
Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
[No Abstract] [Full Text] [Related]
3. Clinical experience with mitomycin C in large infrequent doses.
Godfrey TE; Wilbur DW
Cancer; 1972 Jun; 29(6):1647-52. PubMed ID: 5064044
[No Abstract] [Full Text] [Related]
4. Feasibility study of combining metronidazole with chemotherapy.
Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of weekly administration of anhydroara-5-fluorocytidine (NSC-166641).
Alberto P; Medenica R; Germano G; Bollag W
Cancer Treat Rep; 1976 Mar; 60(3):281-3. PubMed ID: 1260783
[No Abstract] [Full Text] [Related]
6. [Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
Goto T; Furuta I; Urata A; Fukushima M; Okuma K; Oyama A; Murakami M; Ariyoshi Y; Nishimura M; Kurita S
Nihon Gan Chiryo Gakkai Shi; 1983 Dec; 18(8):2054-60. PubMed ID: 6201578
[No Abstract] [Full Text] [Related]
7. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
Perloff M; Muggia FM; Ackerman C
Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
[No Abstract] [Full Text] [Related]
8. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
Nakano H; Kurihara M; Saito R; Takise A; Tsuchiya S; Minato K; Takehara K; Saruya T; Kuwabara H; Fueki R
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2123-7. PubMed ID: 3013099
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of profiromycin vs mitomycin-C utilizing acute intermittent schedules.
Baker LH; Izbicki RM; Vaitkevicius VK
Med Pediatr Oncol; 1976; 2(2):207-13. PubMed ID: 958162
[TBL] [Abstract][Full Text] [Related]
11. [Experimental chemotherapy using a transplanted head and neck cancer model in athymic nude mice].
Hirokawa T
Nihon Jibiinkoka Gakkai Kaiho; 1984 Feb; 87(2):182-94. PubMed ID: 6204032
[No Abstract] [Full Text] [Related]
12. Clinical experience with mitomycin C (NSC-26980).
Whittington RM; Close HP
Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
[No Abstract] [Full Text] [Related]
13. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
14. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
Nishimura M; Sugiura T; Urata A; Ota K
Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
[TBL] [Abstract][Full Text] [Related]
15. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
Leyvraz S; Barrelet L; Savary M; Bernasconi S
Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
17. Comparison of in vitro anticancer chemosensitivity between human squamous cell carcinoma and adenocarcinoma.
Kusumoto T; Sakaguchi Y; Maehara Y; Nakashima T; Furusawa M; Sugimachi K
Oncology; 1992; 49(5):343-6. PubMed ID: 1528569
[TBL] [Abstract][Full Text] [Related]
18. Cytostatic infusion into bronchial arteries in bronchogenic carcinoma.
Ekholm S; Albrechtsson U; Hellekant C; Jonsson K; Nyman U; Tylén U
Ann Radiol (Paris); 1980; 23(4):346-8. PubMed ID: 7387096
[No Abstract] [Full Text] [Related]
19. Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma.
Wheeler RH; Liepman MK; Baker SR; Earhart RH; Bull FE; Ensminger WD
Cancer Treat Rep; 1980; 64(8-9):943-9. PubMed ID: 6160914
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z
Gan To Kagaku Ryoho; 1983 Mar; 10(3):834-9. PubMed ID: 6882001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
